Chronic wounds - is cellular 'reception' at fault? Examining integrins and intracellular signalling

International Wound Journal

Volumn 10, Issue 2, 2013, Pages 185-192

  Widgerow, Alan D ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Chronic wound; Focal adhesion; Integrin; Ligands; Signals

Indexed keywords

CELL RECEPTOR; CELL SURFACE RECEPTOR; FIBRONECTIN; GROWTH FACTOR RECEPTOR; INTEGRIN; INTEGRIN RECEPTOR; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; VERY LATE ACTIVATION ANTIGEN 5; VERY LATE ACTIVATION ANTIGEN 6;

ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL TRANSFORMATION; CHRONIC WOUND; ENDOTHELIUM CELL; EPIDERMIS; EPIDERMIS CELL; EXTRACELLULAR MATRIX; FIBROSIS; FOCAL ADHESION; HUMAN; INTRACELLULAR SIGNALING; KERATINOCYTE; MACROPHAGE; MUSCLE CELL; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; SENESCENCE; SKIN CELL; ULCER; WOUND HEALING IMPAIRMENT;

EID: 84875496529     PISSN: 17424801     EISSN: 1742481X     Source Type: Journal    
DOI: 10.1111/j.1742-481X.2012.00967.x     Document Type: Article

References (66)

1. Agren MS, Werthen M. The extracellular matrix in wound healing: a closer look at therapeutics for chronic wounds. Int J Low Extrem Wounds 2007;6:82-97.
2. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004;36:1031-7.
3. Widgerow AD. Chronic wound exudate - thinking outside the box. Wound Repair Reg 2011;19:287-91.
4. Widgerow AD. Deconstructing the 'stalled wound'- Wounds. Accepted for publication October 2011.
5. Harding KG, Moore K, Phillips TJ. Wound chronicity and fibroblast senescence - implications for treatment. Int Wound J 2005;2:364-8.
6. Clark RA. Fibrin and wound healing. Ann NY Acad Sci 2001;936:355-67.
7. Kim BC, Kim HT, Park SH, Cha JS, Yufit T, Kim SJ, Falanga V. Fibroblasts from chronic wounds show altered TGF-beta-signalling and decreased TGF-beta Type II receptor expression. J Cell Physiol 2003;195:331-6.
8. Ongenae KC, Phillips TJ, Park HY. Level of fibronectin mRNA is markedly increased in human chronic wounds. Dermatol Surg 2000;26: 447-51.
9. Schwartz MA, Ginsberg MH. Networks and crosstalk: integrin signalling spreads. Nat Cell Biol 2002;4:E65-8.
10. Lee JW, Juliano R. Mitogenic signal transduction by integrin-and growth factor receptor-mediated pathways. Mol Cells 2004;17:188-202.
11. Li W, Fan J, Chen M, Guan S, Sawcer D, Bokoch GM, Woodley DT. Mechanism of human dermal fibroblast migration driven by type I collagen and platelet-derived growth factor-BB. Mol Biol Cell 2004;15:294-309.
12. Li W, Henry G, Fan J, Bandyopadhyay B, Pang K, Garner W, Chen M, Woodley DT. Signals that initiate, augment, and provide directionality for human keratinocyte motility. J Invest Dermatol 2004;123:622-33.
13. Telgenhoff D, Shroot B. Cellular senescence mechanisms in chronic wound healing. Cell Death and Differentiation 2005;12:695-8.
14. Ågren MS, Steenfos HH, Dabelsteen S, Hansen JB, Dabelsteen E. Proliferation and mitogenic response to PDGF-BB of fibroblasts isolated from chronic venous leg ulcers is ulcer-age dependent. J Invest Dermatol 1999;112:463-9.
15. Ivaska J, Heino J. Cooperation between integrins and growth factor receptors in signaling and endocytosis. Annu Rev Cell Dev Biol 2011;27:291-320.
16. Barczyk M, Carracedo S, Gullberg D. Integrins. Cell Tissue Res 2010;339:269-80.
17. Velling T, Risteli J, Wennerberg K, Mosher DF, Johansson S. Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1. J Biol Chem 2002;277:37377-81.
18. Xu J, Clark RAF. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996;132:239-49
19. Liu S, Shi-wen X, Blumbach K, Eastwood M, Denton CP, Eckes B, Krieg T, Abraham DJ, Leask A. Expression of integrin β1 by fibroblasts is required for tissue repair in vivo. J Cell Sci 2010;123:3674-82.
20. Hu S, Cui D, Yang X, Hu J, Wan W, Zeng J. The crucial role of collagen-binding integrins in maintaining the mechanical properties of human scleral fibroblasts-seeded collagen matrix. Molecular Vision 2011;17:1334-42.
21. Gardner H, Broberg A, Pozzi A, Laato M, Heino J. Absence of integrin alpha1beta1 in the mouse causes loss of feedback regulation of collagen synthesis in normal and wounded dermis. J Cell Sci 1999;112:263-72.
22. Rayment EA, Upton Z, Shoote GK. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br J Dermatol 2008;158:951-61.
23. White DJ, Puranen S, Johnson MS, Heino J. The collagen receptor subfamily of the integrins. Int J Biochem Cell Biol 2004;36:1405-10.
24. Schultz GS, Ladwig G, Wysocki A. Extracellular matrix: review of its roles in acute and chronic wounds, World wide wounds August 2005. URL www.worldwidewounds.com [accessed on November 2011].
25. Grinnell F, Ho C-H, Wysocki A. Degradation of fibronectin and vitronectin in chronic wound fluid: analysis by cell blotting, immunoblotting, and cell adhesion assays. J Invest Dermatol 1992;98:410-6.
26. Häkkinen l, Koivisto l, Gardner H, Saarialho-Kere U, Carroll JM, Lakso M, Rauvala H, Laato M, Heino J, Larjava H. Increased expression of β6-integrin in skin leads to spontaneous development of chronic wounds. Am J Pathol 2004;164:229-42.
27. Jun J, Lau JF. Cellular senescence controls fibrosis in wound healing. AGING 2010;2:627-31.
28. Bernard D, Gosselin K, Monte D, Vercamer C, Bouali F, Pourtier A, Vandenbunder B. Involvement of Rel/nuclear factor-kappaB transcription factors in keratinocyte senescence. Cancer Res 2004;64:472-81.
29. Van de Berg JS, Robson MC. Arresting cell cycles and the effect on wound healing.Surg. Clin North Am 2003;83:509-20.
30. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. Senescence-associated secretory phenotypes reveal cell nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008;6:2853-68.
31. Erusalimsky JD, Kurz DJ. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol 2005;40:634-42.
32. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 2008;453:314-21.
33. Jun J-I, Lau LF. The matricellular protein CCN1/ CYR61 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol 2010;12:676-85.
34. Stanley A, Osler T. Senescence and the healing rates of venous ulcers. J Vasc Surg 2001;33:1206-11.
35. Kortlever RM, Higgins PJ, Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol 2006;8:877-84.
36. Vande Berg JS, Rose MA, Haywood-Reid PL, Rudolph R, Payne WG, Robson MC. Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta1. Wound Repair Regen 2005;13:76-83.
37. Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MWJ. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol 1992;141:1085-95.
38. Mirastschijski U, Haaksma CJ, Tomasek JJ, Ågren MS. Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds. Exp Cell Res 2004;299:465-75.
39. Mirastschijski U, Schnabel R, Claes J, Schneider W, Ågren MS, Haaksma C, Tomasek JJ. Matrix metalloproteinase inhibition delays wound healing and blocks latent transforming growth factor-β1 promoted myofibroblast formation and function. Wound Repair Regen 2010;18:223-34.
40. Drinkwater SL, Burnand KG, Ding R, Smith A. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers. J Vasc Surg 2003;38:1106-12.
41. Hynes RO. Integrins: bidirectional, allosteric signalling machines. Cell 2002;110:673-87.
42. Connors WL, Jokinen J, White DJ, Puranen JS, Kankaanpa P, Upla P, Tulla, M, Johnson MS, Heino J. Two synergistic activation mechanism of alpha 2 beta 1 integrin mediated collagen binding. Biol Chem 2007;282:14675-83.
43. Vogel WF. Collagen-receptor signalling in health and disease. Eur J Derm 2001;11:506-14.
44. Heino J. The collagen receptor integrins have distinct ligand recognition and signalling functions. Matrix Biol 2000;19:319-23.
45. Eckes B, Zigrino P, Kessler D, Holtkotter O, Shephard P, Mauch C, Krieg T. Fibroblast-matrix interactions in wound healing and fibrosis. Matrix Biol 2000;19:325-32.
46. Zigrino P, Drescher C, Mauch C. Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of alpha2beta1 integrins. Eur J Cell Biol 2001; 80:68-77.
47. Dumin JA, Dickeson SK, Stricker TP, Bhattacharyya-Pakrasi M, Roby JD, Santoro SA, Parks WC. Procollagenase-1 (MMP-1) Binds the alpha2 beta1integrin upon release from keratinocytes migrating on type I collagen. J Biol Chem 2001; 18:18.
48. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg 2002;137:822-7.
49. Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications 2006;20:329-35.
50. Esposito M, Coulthard P, Thomsen P, Worthington HV. Enamel matrix derivative for periodontal tissue regeneration in treatment of intrabony defects: a Cochrane systematic review. J Dent Educ 2004;68:834-44.
51. Mirastschijski U, Konrad D, Lundberg E, Lyngstadaas SP, Jorgensen LN, Ågren MS. Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 2004;12:100-8.
52. Van der Pauw MT, Everts V, Beertsen W. Expression of integrins by human periodontal ligament and gingival fibroblasts and their involvement in fibroblast adhesion to enamel matrix-derived proteins. J Periodontal Res 2002;37:317-23.
53. Suzuki N, Ohyama M, Maeno M, Ito K, Otsuka K. Attachment of human periodontal ligament cells to enamel matrix-derived protein is mediated via interaction between BSP-like molecules and integrin alpha(v)beta3. J Periodontol 2001;72:1520-6.
54. Vowden P, Romanelli M, Peter R, Boström A, Josefsson A, Stege H. The effect of amelogenins (Xelma) on hard-to-heal venous leg ulcers. Wound Repair Regen 2006;14:240-6.
55. Grayson RE, Yamakoshi Y, Wood EJ, Ågren MS. The effect of the amelogenin fraction of enamel matrix proteins on fibroblast-mediated collagen matrix reorganization. Biomaterials 2006;27:2926-33.
56. Groah SL, Libin A, Spungen M, Nguyen K-L, Woods E, Nabili M, Ramella-Roman J, Barritault D. Regenerating matrix-based therapy for chronic wound healing: a prospective within-subject pilot study. Int Wound J 2010;1-11.
57. Ye F, Hu G, Taylor D, Ratnikov B, Bobkov AA, McLean MA, Sligar SG, Taylor KA, Ginsberg MH. Recreation of the terminal events in physiological integrin activation. J Cell Biol 2010;188:157-73.
58. Banno A, Ginsberg MH. Integrin activation. Biochem Soc Trans 2008;36:229-234.
59. Nieswandt B, Moser M, Pleines I, Varga-Szabo D, Monkley S, Critchley D, Fässler R. Loss of talin1 in platelets abrogates integrin activa-tion, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med 2007;204:3113-8.
60. Moser M, Legate KR, Zent R, Fässler R. The tail of integrins, talin, and kindlins. Science 2009;324:895-99.
61. Askari JA, Tynan CJ, Webb SED, Martin-Fernandez ML, Ballestrem C, Humphries MJ. Focal adhesions are sites of integrin extension. J Cell Biol 2010; 188:891-903.
62. Eckes B, Nischt R, Krieg T. Cell-matrix interactions in dermal repair and scarring. Fibrogenesis and Tissue repair 2010;3:4.
63. Leisner TM, Parise LV. Talin's second act-ivation: retraction. Blood 2011;117:1442-3.
64. Robson MC, Phillips TJ, Falanga V, Odenheimer DJ, Parish LC, Jensen JL, Steed DL. Randomized trial of topically applied repifermin (recombinant human keratinocyte growth factor-2) to accelerate wound healing in venous ulcers. Wound Repair Regen 2001;9:347-52.
65. Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becapler-min (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999;7:335-46.
66. Schultz GS, Davidson JM, Kirsner RS, Bornstein P, Herman IM. Dynamic reciprocity in the wound microenvironment. Wound Rep Reg 2011;19:134-48.